AVANOS MEDICAL (NYSE:AVNS) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Key Points

• Avanos Medical reported a quarterly EPS of $0.17, missing the consensus estimate of $0.18 by $0.01.
• The company's stock dropped by 14.3% in midday trading, resulting in a price of $9.64.
• Institutional investors and hedge funds collectively own 95.17% of Avanos Medical's stock, indicating strong institutional support.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) issued its earnings results on Tuesday. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.18 by ($0.01), Zacks reports. The firm had revenue of $175.00 million during the quarter, compared to analysts' expectations of $165.50 million. AVANOS MEDICAL had a negative net margin of 66.89% and a positive return on equity of 6.16%. During the same quarter in the prior year, the company earned $0.34 EPS. AVANOS MEDICAL updated its FY 2025 guidance to 0.750-0.950 EPS.

AVANOS MEDICAL Price Performance

NYSE AVNS traded up $0.04 during mid-day trading on Friday, hitting $10.78. The stock had a trading volume of 787,704 shares, compared to its average volume of 599,158. The firm's 50 day moving average is $11.92 and its 200 day moving average is $13.39. AVANOS MEDICAL has a twelve month low of $9.30 and a twelve month high of $25.36. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.64 and a quick ratio of 1.56. The stock has a market capitalization of $499.96 million, a price-to-earnings ratio of -1.07 and a beta of 1.12.

Institutional Trading of AVANOS MEDICAL

Several large investors have recently added to or reduced their stakes in AVNS. Millennium Management LLC raised its position in shares of AVANOS MEDICAL by 508.3% during the 1st quarter. Millennium Management LLC now owns 547,740 shares of the company's stock worth $7,849,000 after acquiring an additional 457,703 shares in the last quarter. AQR Capital Management LLC increased its holdings in shares of AVANOS MEDICAL by 46.4% in the first quarter. AQR Capital Management LLC now owns 192,864 shares of the company's stock valued at $2,700,000 after purchasing an additional 61,095 shares during the period. Empowered Funds LLC grew its holdings in AVANOS MEDICAL by 5.4% during the first quarter. Empowered Funds LLC now owns 162,182 shares of the company's stock worth $2,324,000 after acquiring an additional 8,348 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in AVANOS MEDICAL by 17.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 140,810 shares of the company's stock worth $2,018,000 after acquiring an additional 20,541 shares during the period. Finally, Intech Investment Management LLC boosted its position in AVANOS MEDICAL by 154.3% during the first quarter. Intech Investment Management LLC now owns 124,061 shares of the company's stock worth $1,778,000 after purchasing an additional 75,279 shares in the last quarter. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered AVANOS MEDICAL from a "strong-buy" rating to a "buy" rating in a research report on Saturday.

AVANOS MEDICAL Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.